Merck snags Chinese obesity drug in nearly $2 billion deal

Less than a minute

Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. Read More

Source link

Oklahoma Digital News2 hours ago

Less than a minute

Oklahoma Digital News

OpenAI brings ChatGPT to WhatsApp

Slim Dunlap, Beloved Replacements Guitarist, Dead at 73

Related Articles

Moody’s downgrades 7 French banks amid debt crisis and poilitical chaos

Senate report calls U.S. effort to keep advanced chips away from China and Russia ‘inadequate’

California declares a state of emergency as a new severe bird flu case was discovered. What it means for the rest of the country

Billionaire Justin Sun allegedly pushed CoinDesk’s new owners to remove banana article, editorial chair Matt Murray resigns

Leave a Reply Cancel reply